CPT code 87660 represents a laboratory molecular diagnostic test for Trichomonas vaginalis using a direct nucleic acid probe. This code identifies a specific laboratory service that supports accurate detection of trichomoniasis, an important sexually transmitted infection with implications for individual patient care and public health surveillance. Nationally, standardized coding for molecular tests like CPT code 87660 enables billing clarity, epidemiologic tracking, and consistent laboratory reporting.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for this molecular diagnostic, typical sites where the service is performed, and the types of reimbursement and policy considerations that commonly affect laboratory molecular testing. The publication also outlines benchmarking and coverage patterns where available, notes common billing modifiers applicable to laboratory services, and summarizes clinical relevance for providers and laboratory administrators.

This summary is presented for a national audience to support billing staff, laboratory managers, and policy analysts in understanding the role and coding of CPT code 87660, and what to expect when billing or reviewing claims for nucleic acid probe testing for Trichomonas vaginalis.